Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Price:
42.18
CNY
-0.02%
Market Closed
Market Cap:
¥13.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
CN |
|
Century Therapeutics Inc
NASDAQ:IPSC
|
US |
|
Enovis Corp
NYSE:ENOV
|
US |
|
M
|
Maple Leaf Foods Inc
OTC:MLFNF
|
CA |
|
C
|
Coles Group Ltd
F:2OF
|
AU |
|
Hochdorf Holding AG
SIX:HOCN
|
CH |
|
Bluerock Residential Growth REIT Inc
F:BKO
|
US |
|
51 Credit Card Inc
HKEX:2051
|
CN |
|
Embry Holdings Ltd
HKEX:1388
|
HK |
|
C
|
Country Group Holdings PCL
SET:CGH
|
TH |
|
RadNet Inc
NASDAQ:RDNT
|
US |
|
S
|
Seach Medical Group Ltd
TASE:SEMG
|
IL |
Multiples-Based Value
The Multiples-Based Value of one
Tibet Rhodiola Pharmaceutical Holding Co
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 42.18 CNY,
Tibet Rhodiola Pharmaceutical Holding Co
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Tibet Rhodiola Pharmaceutical Holding Co Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Tibet Rhodiola Pharmaceutical Holding Co Competitors
Tibet Rhodiola Pharmaceutical Holding Co Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
13.6B CNY | 4.6 | 14.5 | 12.5 | 12.5 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
106.5B USD | 0.3 | 24.5 | 17.3 | 19.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
62.4B USD | 0.2 | 38.4 | 13.6 | 17.2 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.6B USD | 0.2 | 38.5 | 13.6 | 17.2 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.9B USD | 0.2 | 30.6 | 14.8 | 19.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.9B AUD | 2.7 | 34 | 25.3 | 25.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY | 0.2 | 11.1 | 8.7 | 8.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.1B CNY | 1.5 | 17.1 | 13.2 | 13.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD | 0.7 | 21.9 | 10.8 | 15.2 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD | 0.1 | 8.2 | 0.7 | 1 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
